UK To Vaccinate People Against Covid From Next Week, Clears Pfizer Shot
Britain approved Pfizer's COVID-19 vaccine on Wednesday, jumping ahead of the United States and Europe to become the West's first country to formally endorse a jab it said should reach the most vulnerable people early next week.
Prime Minister Boris Johnson touted the medicine authority's approval as a global win and a ray of hope amid the gloom of the...
Oxford Vaccine Likely By April 2021, ₹ 1,000 For 2 Doses: Adar Poonawalla
Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford COVID-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by April for the general public, and will be priced at a maximum of ₹ 1,000 for two necessary doses for the public, depending on the final trial results...
Covaxin, Bharat Biotech’s Coronavirus Vaccine, Cleared For Phase 3 Trials
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials.
The Hyderabad-based vaccine maker had applied to the Drugs Controller General of India (DCGI) on October 2, seeking its permission to conduct Phase 3 trials for its COVID-19 vaccine candidate.
The firm...